Tumour Associated
MarkersCancer and tumour-related conditions often develop silently, with noticeable symptoms appearing only once the disease has progressed. Early detection is therefore essential, as it can significantly improve treatment outcomes and prognosis. Tumour-associated markers are substances produced either by cancerous cells or by the body in response to cancer. These markers can be measured in the blood and provide valuable insights for early detection, ongoing monitoring, and personalised treatment planning. While not definitive diagnostic tools on their own, they form a crucial part of a broader cancer screening and surveillance strategy.
At Fortress Clinical Laboratory, our Tumour-Associated Marker Blood Test provides a comprehensive assessment of key cancer biomarkers. By analysing these markers, your doctor can gain additional information about the risk of tumour development, the progression of existing conditions, and the effectiveness of treatments. Early identification of abnormal marker levels allows for timely medical intervention, improving patient outcomes and supporting long-term health.
Your doctor may recommend a Tumour-Associated Marker Blood Test if you have a family history of cancer, unexplained weight loss, persistent fatigue, unusual lumps or swelling, digestive changes, or if you are undergoing post-treatment monitoring to assess therapy response or detect cancer recurrence. Early testing is crucial to identify potential issues before complications arise and to guide decisions regarding further investigation or intervention.
Tumour-Associated Marker Test Profile includes:
- Cancer Antigen 125 (CA 125) – commonly associated with ovarian cancer.
- Cancer Antigen 15-3 (CA 15-3) – used to monitor breast cancer progression.
- Cancer Antigen 19-9 (CA 19-9) – linked to pancreatic and gastrointestinal cancers.
By monitoring these key biomarkers, the Fortress Clinical Laboratory Tumour-Associated Marker Blood Test provides a thorough overview of tumour activity, supporting early detection, treatment monitoring, and risk assessment. Accurate and timely results enable you and your doctor to make informed decisions regarding preventive strategies, further diagnostic evaluation, and personalised healthcare plans.
With reliable testing from Fortress Clinical Laboratory, you can take a proactive approach to cancer prevention and health management, ensuring long-term well-being, early intervention, and peace of mind.
